Day One Biopharmaceuticals, Inc. Share Price
DAWNDay One Biopharmaceuticals, Inc. Stock Performance
Open $10.82 | Prev. Close $11.32 | Circuit Range N/A |
Day Range $10.47 - $11.38 | Year Range $5.63 - $13.53 | Volume 2,33,570 |
Average Traded $10.90 |
Day One Biopharmaceuticals, Inc. Share Price Chart
About Day One Biopharmaceuticals, Inc.
Day One Biopharmaceuticals, Inc., a commercial-stage company, focused on advancing class medicines for childhood and adult diseases with equal intensity in the United States. The company's lead product candidate is tovorafenib, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed or refractory low-grade glioma; and Ipsen, a frontline raf-altered pLGG which is in Phase III clinical trial stage. It also developing DAY301, which is in phase I clinical trial for adult and pediatric cancers; and VRK1 Inhibitor which is in pre-clinical stage for adult and pediatric cancers. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California.
Day One Biopharmaceuticals, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
09-Jan-26 | $9.46 | $8.94 | -3.41% |
08-Jan-26 | $9.52 | $9.25 | -3.90% |
07-Jan-26 | $8.70 | $9.63 | +11.53% |
06-Jan-26 | $8.54 | $8.63 | +1.05% |
05-Jan-26 | $8.81 | $8.54 | -3.50% |
02-Jan-26 | $9.20 | $8.85 | -5.04% |
31-Dec-25 | $9.21 | $9.32 | +1.53% |